Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy <unk>  is a clinical trial investigating treatments for high risk or terminal prostate cancer. Recruitment started in 2005 and ends in 2022 and in January 2020, over 10,000 participants have joined the trial.
STAMPEDE 
HAS-BLED
AMELY
BIRCH
BIRDEM
FLOW 
CAREN
DizzyFIX